Document:

EXHIBIT 10.1

                     INTELLECTUAL PROPERTY LICENSE AGREEMENT

         THIS AGREEMENT is entered into by Jurak Corporation World Wide, a
Minnesota corporation having its principal place of business at Las Vegas,
Nevada (herein called LICENSEE), and by Jurak Holdings Limited, a body corporate
pursuant to the laws of the Province of Alberta, Canada, having its principal
place of business at Calgary, Canada (herein called LICENSOR) collectively
sometimes to hereinafter as the "PARTIES" or in the singular, "PARTY".

1.       BACKGROUND OF THE AGREEMENT

         1.00 LICENSOR is the owner of certain technical information and related
rights, including trade mark rights and copyrights, relating to the preparation
and sale of certain herbal, phyto-pharmaceutical and neutrabiotic products,
including all know how, formulae, methods, trade secretes, techniques and
processes transferred to LICENSOR by Anthony Carol Jurak in accordance with the
Transfer of Property Agreement between Anthony Carl Jurak and Jurak Holdings
Limited (the "PROPERTY TRANSFER AGREEMENT") clarified by way of an agreement
(the "PROPERTY TRANSFER CLARIFICATION AGREEMENT") effective the same date. A
copy fo the PORERPTY TRANSFER AGREEMENT and the PROPERTY TRANSFER CLARIFICATION
AGREEMENT are attached hereto as Exhibit A, the entire contents of both of which
are incorporated by reference here as if fully stated here and reference to
which is hereby made for all purposes.

         1.01     LICENSEE wishes to acquire and LICENSOR desires to provide
                  LICENSEE with, the exclusive right to use such technical
                  information and related rights, including trade mark rights
                  and copyrights.

         1.02     This AGREEMENT is subject to the Overriding Royalty Grant by
                  LICENSOR to the Children World Wide (the "FOUNDATION"), a
                  California nonprofit corporation, dates as of January 1, 999 a
                  copy of which is attached hereto as Exhibit B, the entire
                  contents of which and all Exhibits and attachments thereto are
                  incorporated by reference here as if fully stated here and
                  reference to which is herby made for all purposes.

2.       DEFINITIONS

         As used herein, the following terms shall have the meanings set forth
below:

         2.00 WORKS OF AUTHORSHIP means all works of authorship rating to the
preparation and sale of herbal, phyto-pharmaceutical and neutrabiotic products
the rights to which LICENSOR now has or in the future during the term of this
AGREEMENT acquires or obtains. COPYRIGHT and COPYRIHTS mean all copyrights and
all other rights in all WORKS OF AUTHORSHIP.

         2.01 TECHNICAL INFORMATION means unpublished research and development
information, unpatented inventions, know-how, trade secretes, methods,
processes, techniques and technical data in the possess of an owned by LICENSOR
as of

                                       1
<PAGE>

the EFFECTIVE DATE OF this AGREEMENT relating to the preparation and sale of
certain herbal, phyto-pharmaceutical and neutrabiotic products, including all
know how, formulae, methods, trade secretes, techniques and processes
transferred to LICENSOR by Anthony Carl Jurak in accordance with the PROPERTY
TRANSFER AGREEMENT and the PROPERTY TRANSFER CLARIFICATION AGREEMENT that are
needed to produce LICENSED PRODUCTS and the LICENSOR has the right to provide to
LICENSEE.

         2.02 TRADE MARKS mean the trade marks, service marks, trade names and
trade dress relating to the preparation and sale of certain herbal,
phyto-pharmaceutical and neutrabiotic products, the rights to which LICENSOR now
has or in the future creates, obtains and/or acquires, and include but are not
limited to the marks, trade names and/or trades dress set forth in, an/or
exemplars of which are attached as part of, Exhibit C hereto.

         2.03 INTELLECTUAL PROPERTY means the combination of TECHNICAL
INFORMATION, COPYRIGHTS, WORKS OF AQUTHORSHIP and TRADE MARKS.

         2.04 LICENSED TERRITORY means worldwide.

         2.05 LICENSED PRODUCTS means products made using, in part or in whole,
any INTELLECTUAL PROPERTY, and includes products and related materials and
services on, or in connection with, which any of the TRADE MARKS and/or WORKS OF
AUTHORSHIP are used. No field of use limitation is imposed by this AGREEMENT.

         2.06 NET SALES PRICE, for the purpose of computing royalties, means
LICENSEE's invoice price of all LICENSED PRODUCTS sold under the LICENSE, f.o.b.
factory, after deduction of return credits, regular trade and quantity
discounts, freight allowances, cash discounts, and agents' and distributors'
commissions. In order to assure to the LICENSOR the full royalty payments
contemplated in this AGREEMENT, LICENSEE agrees that in the event any LICENSED
PRODUCTS shall be sold for purposes of resale either (1) to a corporation, firm,
or association that, or individual who, owns a controlling interest in LICENSEE
by stock ownership or otherwise, or (2) to a corporation, firm, or association
in which LICENSEE stockholders own a controlling interest by stock ownership or
otherwise, the royalties to be paid in respect to such LICENSED PRODUCTS shall
be computed on the price at which the reseller was invoiced by LICENSEE for such
LICENSED PRODUCTS. LICENSOR and LICENSEE agree that LICENSEE may dispose of a
limited quantity of LICENSED PRODUCTS for promotional purposes, and for which no
money is received by or for LICENSEE. Such dispositions will be excluded from
the total NET SALES PRICE for the purposes of computing royalties and overriding
royalties, provided that the quantity is reasonable, in the sole discretion of
LICENSOR, in the circumstances.

                                       2
<PAGE>

         2.07 EFFECTIVE DATE means January 1, 1999.

         2.08 CALENDAR YEAR means a year beginning on January 1 of a given year
of the Julian Calendar and ending on December 31 of the same year of the Julian
Calendar.

         2.09 Under this AGREEMENT, LICENSED PRODUCTS shall be considered to be
sold when shipped or when an invoice is sent out, whichever occurs first, except
that upon any termination of license granted hereunder, all LICENSED PRODUCTS
LICENSEE made by, on, prior to the date of such termination that have not been
shipped or invoiced prior thereto shall be subject to royalty and reported to
LICENSOR in the terminal report required pursuant to Section 7.02. Royalties
paid on LICENSED PRODUCTS that are not accepted by the customer shall be
credited to the LICENSEE.

         2.10 COMMERCIAL USE of LICESNED PRODUCTS means any use of LICENSED
PRODUCTS for which a continuing royalty under Section 4.03 of this AGREEMENT is
payable by LICENSEE to LICENSOR.

         2.11 LICENSE means the intellectual property license granted under
Article 3 of this AGREEMENT.

3.       INTELLECTUAL PROPERTY LICENSE

         3.00 Subject to the terms and condition of this AGREEMENT, LICENSOR
hereby grants to LICENSEE, throughout the LICENSED TERRITORY an exclusive
license:

         (1)      To use the INTELLECTUAL PROPERTY to make LICENSED PRODUCTS;

         (2)      T o use the INTELLECTUAL PROPERTY on and/or in connection with
                  any and all LICENSED PRODUCTS and related materials and
                  services, including but not limited to promotional materials;

         (3)      To use, reproduce, perform and make derivative works of the
                  WORKS OF AUTHORSHIP. LICENSEE shall mark each page of each
                  reproduction of any and all WORKS OF AUTHORSHIP with a
                  copyright notice containing the following three elements: (a)
                  "COPYRIGHT (C)"; (b) the year of first publication of the
                  particular WORK OF AUTHORSHIP; and (c) "JURAK HOLDINGS
                  LIMITED. ALL RIGHTS RESERVED." LICENSEE shall mark the first
                  or the last page of each reproduction of any and all WORKS OF
                  AUTHORSHIP with a further copyright notice containing
                  essentially:

                           THIS DOCUMENT IS PROTECTED BY COPYRIGHT, AND CONTAINS
                           INFORMATION PROPRIETY TO JURAK HOLINGS, LIMITED. ANY
                           COPYING, ADAPTATIONS, DISTIRBUTION, PUBLIC

                                       3
<PAGE>

                           PERFORMANCE, OR PUBLIC DISPLAY OF THIS DOCUMENT
                           WITHOUT THE EXPRESS WRITTEN CONSENT OF JURAK
                           HOLDINGS, LIMITED IS STRICTLY PROHIBITED. THE RECEIPT
                           OR POSSESSION OF THIS DOCUMENT DOES NOT CONVEY ANY
                           RIGHTS TO REPRODUCE OR DISTRIBUTE ITS CONTENTS, OR TO
                           MANUFACTURE, USE OR SELL ANYTHING THAT IT MAY
                           DESCRIBE, IN WHOLE OR IN PART, WITHOUT THE SPECIFIC
                           WRITTEN CONSENT OF JURAK HOLINGS, LIMITED.

         3.01 LICENSOR shall within sixty (60) days of the EFFECTIVE DATE of
this AGREEMENT, to the extent it has not already done so, make available to
LICENSEE for its use TECHNICAL INFORMATION in LICENSOR's possession needed to
make LICENSED PRODUCTS.

         3.02 LICENSEE shall not disclose any unpublished TECHNICAL IFNORMATION
furnished by LICENSOR pursuant to Section 3.01 above to third parties during the
term of this AGREEMENT, or any time thereafter, provided, however, hat
disclosure maybe made of any such TECHNIAL INFORMATION at any time (1) with the
prior written consent of LICENSOR, or (2) to the extent necessary to use and/or
market LICENSE PRODUCTS, or (3) to the extent necessary to enable sublicensees
of LICENSEE to use and/or market LICENSED PRODUCTS, or (4) after the same shall
have become public through no fault of LICENSEE. The provisions and obligations
under Section 3.02 of this AGREEMENT shall survive early and normal termination
and expiration of this AGREEMENT and shall continue in full force and effect
until such time as LICENSOR elects to abandon such terms.

         3.03 LICENSEE shall not use any TECHNIAL INFORMATION furnished by
LICENSOR other than in the manufacture of LICENSED PRODUCTS and only during the
term of AGREEMENT, provided, however, that other use of such TECHNIAL IFNORMIAON
may be mad e(1) with the prior written consent of LICENSOR, or (2) after the
same shall have become public through no fault of LICENSEE. The provisions and
obligations under Section 3.03 of this AGREEMENT shall survive early and normal
terminate and expiration of this AGREEMENT and shall continue in full force and
effect until such time as LICENSOR elects to abandon such terms.

         3.04 LICENSOR does not warrant the accuracy of the TECHNICAL
INFORMATION; nor does LICENSOR warrant that LICENSED PRODUCTS produced in
accordance with such information will be free from claims of infringement of the
patents, trade secrets, copyrights, trade marks, or any other intellectual
property rights of any third party. LICENSOR shall not, except as provided in
this Article 3, be under any liability arising out of the supplying of
information under, in connection with, or as a result of this AGREEMENT, whether
on warranty, contract, negligence, or otherwise. The provisions and obligations
under Section 3.04 of this AGREEMENT shall survive early and normal termination
and expiration of this AGREEEMNT and shall continue in full force and effect
until such time as LICENSOR elects to abandon such terms.

                                       4
<PAGE>

         3.05 LICENSEE shall only use the TRADE MARKS in the form and manner
authorized in advance in writing by LICENSOR.

         3.06 LICENSEE acknowledges the validity of the TRADE MARKS and shall
not at any time during the term of this AGREEMENT or thereafter directly or
indirectly, by itself or through its servants, agents, related companies,
successors or assigns, contest or assist any other company or person in
contesting the validity of the TRADE MARKS or the right, title and interest of
this LICENSOR to the TRADE MARKS. The provisions and obligations under Section
3.06 of this AGREEMENT shall survive early and normal termination and expiration
of this AGREEMENT and shall continue in full force and effect until such time as
LICENSOR elects to abandon such terms.

         3.07 LICENSOR shall have the right of prior review and approval of the
nature and quality of LICENSED PRODUCTS on which, or in connection with which,
one or more of the TRADE MARKS are used and the form of the TRADE MARKS so use,
and LICENSEE agrees to abide by the directions of the LICENSOR in this regard.
LICENSOR shall have the right to inspect LICENSEE'S facilities and samples of
LICENSED PRODUCTS on which, or in connection with which, one or more of the
TRADE MARKS are used at any time upon request.

         3.08 LICENSEE agrees that all use of the TRADE MARKS will inure to the
benefit of LICENSOR and LICENSEE shall have no right in the TRADE MARKS except
as provided by this AGREEMENT.

         3.09 LICENSEE shall, and LICENSEE shall ensure that each sublicensee
shall, indemnify, hold harmless, and keep the LICENSOR indemnified from and
against all claims, demands, actions, suits, proceedings, judgments, damages,
costs, charges and expenses whatsoever arising directly or indirectly out of the
use of the INTELLECTUAL PROPERTY and out of the manufacture, distribution, sale
or use of the LICENSED PRODUCTS by or on behalf of LICENSEE and each respective
sublicense or anything connected with or consequent upon any such manufacture,
distribution, sale, or use. The provisions and obligations under Section 3.09 of
this AGREEMENT shall survive early and normal termination and expiration of this
AGREEMENT and shall continue in full force and effect until such time as
LICENSOR elects to abandon such terms.

         3.10 LICENSEE is free to use the intellectual property of its own and
of others as provided by license, acquisition or other lawful manner, including
trade marks, service marks, patents, copyrights, works of authorship, and any
all other types of intellectual property created by LICENSEE, or otherwise
acquired, licensed, or obtained by LICENSEE and nothing in this AGREEMENT shall
prohibit such use.

         3.11 LICENSEE hereby confirms an understanding and agreement between
LICENSOR and LICENSEE, and hereby agrees, that: (1) all use of the WORKS OF
AUTHORSHIP by LICENSEE has been and will be under the terms of the license to
the WORKS OF AUTHORSHIP and the COPYRIGHTS therein granted hereunder to
LICENSEE; and (2) at any time during and/or after the term for this AGREEMENT,
LICENSEE shall execute and deliver to LICENSOR any and all conveyance
instruments and/or shall provide testimony and/or shall perform any other acts
deemed necessary to

                                       5
<PAGE>

carry out the intent of this AGREEMENT regarding the right, title, interest,
benefit, ownership or other right to the COPYRIGHTS and WORKS OF AUTHORSHIP as
LICENSOR deems necessary and desirable at the request of LICENSOR and LICESNOR
shall reimburse LICENSEE for any and all costs reasonably incurred by LICENSEE
in performance of this subparagraph 3.11(2).

         3.12 LICENSEE hereby confirms an understanding and agreement between
LICENSOR and LICENSEE, and hereby agrees, that: (1) LICENSOR is and shall be the
exclusive owner of all TRADE MARKS: (2) to the extent LICENSEE now has, o in the
future obtains, any rights in the TRADE MARKS, LICENSEE agrees to and does
hereby assign to LICENSOR all right, title and interest in and to all TRADE
MARKS, together with the goodwill of the business connected with the use of and
symbolized by the TRADE MARKS; (3) all use of the TRADE MARKS by LICENSEE has
been and will be under the terms of the license to the TRADE MARKS granted
herein to LICENSEE; AND (4) at any time during and/or after the term of this
AGREEMENT, LICENSEE shall execute and deliver to LICENSOR any and all conveyance
instruments and/or shall provide testimony and/or shall perform any other acts
deemed necessary to carry out the intent of this AGREEMENT regarding the right,
title, interest, benefit, ownership or other right to the TRADE MARKS as
LICENSOR deems necessary and desirable at the request of LICENSOR and LICENSOR
shall reimburse LICENSEE for any and all costs reasonably incurred by LICENSEE
in performance of this subparagraph 3.12(4).

4.       ROYALTIES AND OVERRIDING ROYALTIES

         4.00 LICENSEE shall pay to the FOUNDATION a continuing Overriding
Royalty Interest of the percent of the NET SALES PRICE of all LICENSED PRODUCTS
sold under the LICENSE (hereinafter "OVERRIDING ROYALTY INTEREST") according to
an annual determination of the total annual amount of NET SALES PRICE of all
LICENSED PRODUCTS sold under the LICENSE pursuant to the schedule presented in
Exhibit B attached to the Overriding Royalty Grant, itself attached as Exhibit B
hereto. The amount of net sales to which the NET SALES PRICE refers shall be
those sales made during the calendar quarter immediately preceding the quarter
in which the OVERRIDING ROYALTY is due, as set forth in Section 7.00 below. The
percentage of NET SALES PRICE due as OVERRIDING ROYALTY INTEREST will be
determined by the PARTIES on an annual basis, beginning on the EFFECTIVE DATE of
this AGREEMENT and on the one year anniversary of the EFFECTIVE DATE every year
thereafter for the duration of the term of this AGREEMENT and for every
extension thereof (the "ANNUAL DETERMINATION DATE"). The percentage of NET SALES
PRICE due during any year as OVERRIDING ROYALTY INTEREST will be determined by
the PARTIES based on a report by LICENSE reporting the amount of net sales of
all LICENSED PRODUCTS sold under the LICENSE during the year immediately
preceding the EFFECTIVE DATE or the annual anniversary of the EFFECTIVE DATE, as
the case may be (the "LICENSEE'S ANNUAL REPORT").

         4.01 LICENSEE shall pay to LICENSOR a continuing royalty of the percent
of the NET SALES PRICE of all LICENSED PRODUCTS sold under the LICENSE according
to an annual determination for the total annual amount of NET SALES PRICE of all
LICENSED PRODUCTS used, sold, or otherwise disposed of under the LICENSE
pursuant to the schedule attached as Exhibit D hereto (hereinafter "CONTINUING

                                       6
<PAGE>

ROYALTY" or "CONTINUING ROYALTIES"). The amount of net sales to which the NET
SALES PRICE refers shall be those sales made during the calendar quarter
immediately preceding the quarter in which the ROYALTY is due, as set forth in
Section 7.00 below. The percentage of NET SALES PRICE due as CONTINUE ROYALTY
will be determined by the PARTIES on an annual basis, beginning on the EFFECTIVE
DATE of this AGREEMENT and on the one year anniversary of the EFFECTIVE DATE
every year thereafter for the duration of the term of this AGREEMENT and for
every extension thereof. The percentage of NET SALES PRICE due during any year
as CONTINUING ROYALTY will be determined by the PARTIES based on the amount of
net sales of all LICENSED PRODUCTS sold under the LICENSE during the year
immediately preceding the EFFECTIVE DATE or the annual anniversary of the
EFFECTIVE DATE, as the case may be. LICENSEE shall furnish LICENSOR with
LICENSEE'S ANNUAL REPORT not later than one week prior to the ANNUAL
DETERMINATION DATE. LICENSOR will notify LICENSEE and FOUNDATION within thirty
(30) days after the ANNUAL DETERMINATION DATE of the percentage of NET SALES
PRICE due during the year following the particular ANNUAL DETERMINATION DATE as
OVERRIDING ROYALTY INTEREST and as CONTINUING ROYALTY.

         4.02 For every calendar year during the tem of this AGREEMENT, the
CONTINUING ROYALTIES for any given LICENSED PRODUCTS shall not exceed eight
percent (8%) of the NET SALES PRICE.

5.       MINIMUM ROYALTIES

         5.00 LICENSEE shall pay to LICENSOR ROYALTIES as stated in Article 4
Sections 4.00, 4.01 and 4.02 but in no event shall ROYALTIES under Section 4.00
for the FIRST CALENDAR YEAR OF THIS AGREEMENT for practice of the INTELLECTUAL
PROPERTY in the LICENSED TERRITORY be less than $10,000. For every CALENDAR YEAR
beginning after the last day of the FIRST CALENDAR YEAR OF THIS AGREEMENT, for
the remaining term of this AGREEMENT, the CONTINUING ROYALTIES for practice of
the INTELLECTUAL PROPERTY in the LICENSED TERRITORY shall not be less than the
following minimum royalties during each of the CALENDAR YEARS indicated:

                                         Minimum CONTINUING ROYALTY, U.S. $ per
                                         CALENDAR YEAR*
CALENDAR YEAR                            Exclusive License
-------------------------------------------------------------------------------
2000                                     $10,000
2001                                     $100,000
2002                                     $200,000
2003 and each
CALENDAR YEAR
Thereafter during the first 10 years
of the term of this AGREEMENT*           $500,000
___________________________
*Expressed in terms of aggregate payments to LICENSOR based on LICENSEE's Net
Sales Price after taxes, if any, withheld at the source.

                                       7
<PAGE>

*LICENSOR shall establish the minimum royalties for each subsequent 10 year
portion of the Term and provide LICENSEE with written notice of such amounts 30
days prior to the end of each ten year period.

         5.01 LICENSOR may, by written notice to LICENSEE, terminate this
AGREEMENT at any time after January 1, 2002, if LICENSEE has not sold LICENSED
PRODUCTS sufficient to generate earned ROYALTIES as provided by Section 4.01 and
4.02 of this AGREEMENT during one year period in the amount of one hundred
thousand dollars ($100,000).

         5.02 All payments to LICENSOR specified by this AGREEMENT shall be made
in the City of Calgary, Alberta, in U.S. currency. All payments to LICENSOR due
shall be made without deduction for taxes, assessments, or other charges of any
kind that may be imposed on LICENSOR by any government other than that of the
United States, or any political subdivision of such other government, with
respect to any amounts payable to LICENSOR pursuant to this AGREEMENT. A
percentage of the gross payment to LICENSOR will be withheld by LICENSEE as
withholding tax in accordance with an subject to the Convention between the
United States of America and Canada With Respect to Taxes On Income and On
Capital. As of the effective date of this AGREEMENT, the percentage as required
by said Convention is 10% and reduced to a net 5% in accordance with the North
American Free Trade Agreement.

         5.03 All payments to the FOUNDATION specified by this AGREEMENT shall
be made to the home office of the FOUNDATION at 1181, Grier Drive, Suite C, Las
Vegas, Nevada.

6.       SUBLICENSING

         6.0 LICENSEE shall have the exclusive right under this AGREEEMNT to
grant sublicenses to others at royalty rtes not less than those required to be
paid in Article 4 of this AGREEMENT.

         6.01 In respect to sublicenses granted by LICENSEE under this Article
6, LICENSEE shall pay over to LICENSOR that proportion of royalties payable by
its sublicensees necessary to yield LICENSOR returns on LICENSED PRODUCTS sold
by such sublicensees equal to the amounts that it would have received from
LICENSEE on equivalent LICENSED PRODUCTS sold by it.

         6.02 If this AGREEMENT becomes nonexclusive, expires, or is terminated
for any reason, LICENSEE shall immediately assign all of its right, title and
interest to all sublicenses hereunder to LICENSOR, including the right to
receive all income from sublicessess. LICENSEE shall, prior to execution of each
sublicense hereunder, make the sublicensee aware of the provision of this
Section 6.02. Any and all sublicenses granted by LICENSEE shall contain
provisions corresponding to those of this Section 6.02 respecting termination
and the conditions of assignment of sublicenses.

         6.03 The granting by LICENSEE of sublicenses under the INTELLECTUAL
PROPERTY licensed by this AGREEMENT shall be in the discretion of LICNESS, and
LICENSEE shall have the sole power to determine whether or not to grant
sublicenses and

                                       8
<PAGE>

subject to Sections 6.00, 6.02, 6.04, 6.05, 6.06, 6.07 and 6.08 of this
AGREEMENT, the royalty rates and terms and conditions of such sublicenses.

         6.04 LICENSEE shall insure that all LICENSED PRODUCTS and related
materials and services in respect of which all sublicenses use the INTELLECTUAL
PROPERTY shall be of the same or higher standards of quality in materials,
design and workmanship as the LICENSED PRODUCTS and related materials and
services in relations to which the INTELLECTUAL PROPERTY is used by LICENSEE at
any time.

         6.05 LICENSEE shall take appropriate actions to insure that all
sublicensees properly use the TRADE MARKS and mark the LICENSED PRODUCTS with
the TRADE MARKS so as to void loss of the protection of such TRADE MARKS in any
country.

         6.06 LICENSEE agrees that, and shall insure, that the manufacture,
distribution, sale, installation, and serviced of LICENSED PRODUCTS and sue of
the INTELLECTUAL PROPERTY shall be at the sole risk in all respects of LICENSEE
or any sublicense as the case may be, and neither LICENSEE nor any sublicensee
shall have any claim of any nature whatsoever against LICENSOR in relation to
any LICENSED PRODUCTS, or the INTELLECTUAL PROPERTY. The provisions and
obligations under Section 6.06 of this AGREEMENT shall survive early and normal
termination and expiration of this AGREEMENT and shall continue in full force
and effect until such time as LICENSOR elects to abandon such terms.

         6.07 LICENSEE shall insure that LICENSEE and each sublicense takes out
and maintains or causes to be taken out and maintained throughout the term of
the sublicense agreement a broad form of liability insurance policy with such
insurer containing such conditions and for such amount as the LICENSOR may
reasonably require and which shall include LICENSOR and LICENSEE as additional
insured parties under the policy. Such liability insurance policy shall provide
that the insurer shall give to LICENSOR and LICENSEE thirty (30) days' advance
written notice prior to terminating such policy and prior to changing any
provisions of such policy. LICENSEE shall insure that LICENSEE and each
sublicense notifies LICENSOR and LICENSEE annually after renewal of all details
concerning such insurance. LICENSOR agrees that at thee time of execution of
this AGREEMENT, US $10,000,000 is an appropriate amount for such insurance.

         6.08 LICENSEE shall insure that any and all sublicense agreements
provide for the maintenance of, the inspection of, and the audit of, the
sublicensee's records by LICENSOR and/or LICENSEE according to terms consistent
with the terms provided in Sections 11.00 and 11.01 of this AGREEMENT.

7.       PAYMENTS

         7.00 Not later than the last day of each month, LICNESEE shall furnish
to LICENSOR a written statement in such detail as LICENSOR may reasonably
require of all amounts due pursuant to Sections 4.01 and 4.02 and 5.00 for the
monthly periods ended the last days of the preceding month, and shall pay to
LICENSOR all amounts due to LICENSOR. In the event that the amounts due at the
end of any CALENDAR YEAR do not equal the minimum ROYALITES or minimum
CONTINUING ROYALTIES

                                       9
<PAGE>

specified in Article 5 for said CALENDAR YEAR, LICENSEE shall pay to LICENSOR,
ON THE LAST DAY OF THE FOLLOWING January, the amount required to satisfy the
minimum ROYALTY or minimum CONTINIUING ROYRALTY obligation for the preceding
CALENDAR YEAR. Such amounts are due ton the dates that the statements are due.
If not amount is accrued during any monthly period, a written statement to that
effect shall be furnished.

         7.01 Payments provided for in this AGREEMENT, when overdue, shall bear
interest at a rate per annum equal to one percent (1%) in excess of the "prime
rate" published by The Wall Street Journal at the time such payment is due, and
for the time period until payment is received by LICENSOR.

         7.02 If this AGREEMENT is for any reason terminated before all of the
payments herein provided for have been made (including minimum ROYALTIES for the
year in which the AGREEMENT is terminated), LICENSEE shall immediately submit a
terminal report and pay to LICENSOR any remaining unpaid balance even though the
due date as above provided has not been reached.

         7.03 Not later than the last day of each month, LICENSEE shall furnish
to the FOUNDATION a written statement In such detail as the FOUNDATION may
reasonably require of all amounts due pursuant to Section 4.00 for the monthly
periods ended the last day so of the preceding month, and shall pay to the
FOUNDATION all amounts due to the FOUNDATIN. Such amounts are due at the dates
the statements are due. If no amount is accrued during any monthly period, a
written statement to that effect shall be furnished.

8.       REPRESENTATIONS AND DISCLAIMER OF WARRANTIES

         8.00 NOTHING IN THIS AGREEMETN SHALL BE DEEMED TO BE A REPRESTATION OR
WARRANTY BY LICENSOR OF THE ACCURACY, SAFETY, OR USEFULNESS OF ANY PURPOSE OF
ANY TECHNICAL INFORMATION, INTELLECTUAL PROPERTY, TECHNIQUES, OR PRACTIVES AT
ANY TIME MADE AVAILABILE BY LICENSOR. LICENSOR SHALL HAVE NO LIABILITY
WHATSOEVER TO LICENSEE OR ANY OTHER PERSON INCLUDING A SUBLICENSEE FOR OR ON
ACCOUNT OF ANY INJURY, LOSS, OR DAMAGE, OF ANY KIND OR NATURE, SUSTAINED BY, OR
ANY DAMAGE ASSESSED OR SSERTED AGAINST, OR ANY OTHER LIABILITY INCURRED BY OR
IMPOSED ON LICENSEE OR ANY OTHER PERSON, ARISING OUT OF OR IN CONNECTION WITH OR
RESULTING FROM (A) THE USE OF ANY TECHNICAL INFORMATION, INTELLECTUAL PROPERTY,
TECHNIQUES, OR PRACTICES DISCLOSED BY LICENSOR; OR (B) ANY ADVERTISING OR OTHER
PROMOTIONAL ACTIVITIES WITH RESPECT TO ANY OF THE FOREGOING, AND LICENSEE SHALL
HOLD LICENSOR, AND ITS OFFICERS, EMPLOYEES, AND AGENTS, HARMLESS IN THE EVENT
LICENSOR, OR ITS OFFICERS, EMPLOYEES, OR AGENTS, IS HELD LIABLE.

                                       10
<PAGE>

         8.01 IN NO EVENT WILL LICENSOR BE LIABLE FOR ANY INCIDENTAL OR
CONSEQUENTIAL DAMAGES DUE TO BREACH OF LICENSOR'S OBLIGATIONS HEREUNER OR DUE TO
THE MANUFACTURE, SALE, OFFER FOR SALE, IMPORT, OR EXPORT OF LICENSED PRODUCTS BY
LICENSEE OR SUBLICENSEES OR DUE TO THE USE OR PRACTICE BY LICENSEE OR
SUBLICENSEES OF THE INTELLECTUAL PROPERTY.

         8.02 The provisions and obligation sunder Article 8 of this AGREEMENT
shall survive early and normal termination and expiration of this AGREEMENT and
shall continue in full force and effect until such time as LICENSOR elects to
abandon such terms.

9.       TERM AND TERMINATION

         9.00 The term of this AGREEMENT is perpetual (the "TERM") commencing on
the EFFECTIVE DATE of this AGREEMENT unless terminated in accordance with other
provisions of this AGREEMENT.

         9.01 LICENSEE's obligations under certain sections of this AGREEMENT
Relating to the INTELLECTUAL PROPERTY, including the obligation to pay
CONTINUING ROYALTIES for the use of the INTELLECTUAL PROPERTY as specified in
Section 4.01, and the obligation to pay OVERRIDING ROYALTIES to the FOUNDATION
as specified in Section 4.00 shall terminate upon the expiration of the term of
this AGREEMENT, unless sooner terminated, but the provisions and obligations
under Section 3.02, 3.03, 3.04, 3.06, 3.09, 6.06, 16.00, 17.00, 19.00, 20.00 and
Articles 8 and 10 of this AGREEMENT shall survive early and normal termination
and expiration of this AGREEMENT and shall continue in full force and effect
until such time that LICENSOR elects to abandon such terms.

         9.02 LICENSEE may terminate this AGREEMENT in whole at any time upon
sixty (60) days' written notice in advance to LICENSOR.

         9.03 If LICENSOR shall be in default of any obligation hereunder, or if
any PARTY shall be adjudged bankrupt, or become insolvent, or make an assignment
for the benefit of creditors, or be placed in the hands of a receiver or a
trustee in bankruptcy, the other PARTY may terminate this AGREEMENT by giving
sixty (60) days' notice by Registered Mail to the other PARTY, specifying the
basis for termination. If within sixty (60) days after the receipt of such
notice, the PARTY who received notice shall remedy the condition forming the
basis for termination, such notice cease to be operative, and this AGREEMENT
shall remedy the condition forming the basis for termination, such notice shall
cease to be operative, and this AGREEMENT shall continue in full force. This
AGGREMENT shall automatically terminate: (a) in the event the assets of LICENSEE
are seized or attached in conjunction with any action against it by a third
party; or (b) an attempt by LICENSEE to assign this AGREEMENT is made contrary
to the terms of this AGREEMENT.

                                       11
<PAGE>

         9.04 In the event of termination of this AGREEMENT, LICENSEE shall have
the right to well or otherwise dispose of all products in LICENSEE's inventory
on the date of termination which would constitute LICENSED PRODUCTS prior to the
termination of this AGREEMENT and to provide all related materials and services
necessary to sell such products. In the event of termination of the AGGREEMENT,
LICENSEE shall further have the right to use the INTELLECTUAL PROPERTY to
manufacture products which would constitute LICENSED PRODUCTS prior to the
termination of this AGREEMENT sufficient to fulfill, and to fulfill, all
contracts and orders for sale of LICENSED PRODUCTS under which LICENSEE is
obligated on the date of termination and to provide all necessary materials and
services necessary to fulfill such contract and orders for sale, proved LICENSEE
pays royalties and overriding royalties on all such sales as required in
Articles 4 and 5 hereof and provided that all such sales are completed within
six (6) months after the date of termination. In the event this AGREEMENT is
terminated, after LICENSEE has sold or otherwise disposed of all products in
LICENSEE's inventory on the date of termination which would constitute LICENSED
PRODUCTS prior to the termination of this AGREEMENT and after LICENSEE has
fulfilled all contracts and orders for sale of LICENSED PRODUCTS under which
LICENSEE is obligated on the date of termination, notwithstanding the provisions
of Section 3.02 and 3.03, in the event this AGREEMENT terminates prior to ten
(10) years from the EFFECTIVE DATE of this AGREEMENT, LICENSEE agrees (1) that
it will not sell or distribute LICENSED PRODUCTS incorporating or made using the
TECHNICAL INFORMATION unless first negotiating a separate license for the
TECHNICAL INFORMATION, or otherwise obtaining LICENSOR's prior written
authorization; and (2) that it will promptly transfer to LICENSOR all written
copies of unpublished TECHNICAL INFORMATION in its passion and delete all the
TECHNICAL INFORMATION from all computer data bases in LICENSEE's possession and
/or control.

         9.05 Either PARTY may, immediately upon notice, terminate this
AGREEMENT in part or in its entirety if: (1) Such termination is necessary to
comply with an order or official request of the government of the termination
PARTY; or (2) Normal conduct of the business of the other PATEY as a private
enterprise ceases or is substantially altered as a consequence of a FORCE
MAJEURE.

         9.06 The PARTIES acknowledge that LICENSEE may not have a need to use,
or may otherwise determine that it will not use, certain items of INTELLECTUAL
PROPERTY the use of which is licensed hereunder. Termination of this AGREEMENT
in part is provided below;

         (1) At any time, LICENSEE may terminate this AGREEMENT in part as to
one or more specific items of INTELLECTUAL PROPERTY including one or more
specific items of TECHNICAL INFORMATION, and/or one or more COPYRIGHTS, WORKS OF
AUTHORSHIP or TRADE MARKS. To terminate this AGREEMENT in part as to one or more
specific items of INTELLECTUAL PROPERTY, LICENSEE shall notify LICENSOR in
writing, which writing will specifically identify the particular item or items,
as the case may be, of ITNELLECTUAL PROPERTY for which this AGREEMENT is to be
terminated.

                                       12
<PAGE>

         (2) Subject to the terms and provisions specified in this subparagraph
9.06(2), at any time after one year after the EFEFECTIVE DATE, LICENSOR may
terminate this AGREEMENT in part as to one or more specific items of
INTELLECTUAL PROPERTY including one or more specific items of TECHNICAL
INFORMATION, and/or one or more COPYRIGHTS, WORKS OF AUTHORSHIP or TRADE MAKS if
LICENSEE fails to use one or more specific items of INTELLECTUAL PROPERTY for
more that a period of six (6) months. To terminate this AGREEMENT in part as to
one or more specific items of INTELLECTUAL PROPERTY, LICENSOR shall notify
LICENSEE in writing of LICENSOR's intention to terminate the AGREEMENT in part
and shall specifically identify the particular item or items, as the case may
be, of INTELLECTUAL PROPERTY for which LICENSOR intends to terminate this
AGREEMENT. LICENSEE shall have thirty (30) days from the date of LICENSOR's
written notification in which to provide to LICENSOR documentary evidence to
show that LICENSEE has begun using and/or plans to use the item or items of
INTELLECTUAL PROPERTY for which LOCENSOR has specified this AGREEMENT is to be
terminated. if licensee fails to provide any documentation evidence of use and
/or planned use within the specified period, LICENSOR may terminate the
AGREEMENT as to the specified item or items immediately after the expiration of
the specified thirty day period.

         (3) Upon termination in part of this AGREEMENT as to one or more items
of INTELLECTUAL PROPERTY, all rights are granted herein as to the item or items
of INTELLECTUAL PROPERTY for which the AGREEMENT is terminated shall revert to
LICENSOR who may license others to use the item or items of INTELLECTUAL
PROPERTY so terminated from this AGREEMENT to any other person or entity in any
manner or way whatsoever; this AGREEMENT will continue in full force and effect
for all INTELLECTUAL PROPERTY not so terminate.

10.      PATENTS AND IMPROVEMENTS; DERIVATIVE WORKS; NEW WORKS OF AUTHORSHIP;
         NEW TRADE MARKS

         10.00 All discoveries, improvements and inventions, conceived during
the term of this AGREEMENT, including but not limited to improvement inventions,
and any improvements, to the TECHNICAL INFORMATION, made solely by LICENSEE's
personnel shall be the exclusive property of LICENSEE.

         10.01 All discoveries, improvements and inventions, conceived during
and after the term of this AGREEMENT, including but not limited to improvement
inventions, and any improvements, to the TECHINICAL INFORMATION, made solely by
the LICENSOR's personnel shall be the exclusive property of LICENSOR.

         10.02 All discoveries, improvements and inventions, conceived during
the term of this AGREEMENT, including but not limited to improvement inventions,
and any improvements, to the TECHINICAL INFORMATION, made jointly by LICENSEE's
and LICENSOR's personnel shall be jointly owned by LICENSEE and LICENSOR without
accounting to either PARTY. In the event of a joint invention or other jointly
developed intellectual property, the patent expenses or expenses incurred in the
protection and registration of the intellectual property shall be on a joint
invention, or an application to protect other jointly developed intellectual
property and not to share the

                                       13
<PAGE>

expenses thereof, the other PARTY may file an application for the protection of
the jointly developed intellectual property at its own expense and shall have
sole control of the prosecution thereof.

         10.03 All Derivative Works of the WORKS OF AUTHORSHIP created solely by
LICENSEE shall belong to LIENSEE.

         10.04 All New Works of Authorship created solely by LICENSEE after the
EFFECTIVE DATE of this AGREEMENT, whether or not the New Works of Authorship
relate to the preparation and sale of herbal, phyto-pharmaceutical and
neutrabiotic products, shall belong to LICENSEE.

         10.05 All New Trade Marks, Service marks, Trade Names, and Trade Dress
created and/or used solely by LICENSEE after the EFFECTIVE DATE of this
AGREEMENT, whether or not the New Trade Marks, Service Marks, Trade Names, and
Trade Dress relate to the preparation and sale of herbal Phyto-phamaceutical and
neutrabiotic product, shall belong to LICENSEE.

         10.06 Each PARTY shall have the sole right to file and prosecute patent
applications, applications for registration of trade and service marks, and
applications for registration of copyright for works of authorship solely
belonging to or owned by it and to determine whether or not, and where, to file
such application, to abandon the prosecution of any such application, or to
discontinue the maintenance of any such application. Each PARTY shall disclose
to the other its intent to file such an application, including a patent
application on each invention. Either PARTY shall have the above-mentioned
rights regarding patents in jointly owned inventions and intellectual property,
except that any PARTY planning to abandon a patent or other intellectual
property protection application on a jointly owned invention or jointly
developed intellectual property shall first offer to the other PARTY the
opportunity to continue with such application or patent. The PARTIES shall
extend the cooperation necessary to file, prosecute and maintain patent
applications, patents on jointly owned inventions, and jointly owned and
developed intellectual property.

         10.07 It is understood that the ownership by LICENSEE of any inventions
and/or improvements to the TECHINICAL INFORMATION does not include a license to
the TECHINICHAL INFORMATION beyond the term of this AGREEMENT. The PARTIES shall
separately negotiate licenses to the TECHINICAL INFORMATION to the extent
necessary for LICENSEE to practice any and all inventions or improvements to the
TECHNICAL INFORMATION beyond the term of this AGREEMENT.

         10.08 In exchange for the licenses granted to LICENSEE hereunder,
LICENSEE herby agrees to grant LICENSOR an perpetual, non-exclusive, fully-paid
up, royalty-free, worldwide right and license, with the right to sublicense: (1)
all Derivative Works of the WORKS OF AUTHORSHIP created solely by LICENSEE; (2)
all New Works of Authorship created solely by LICENSEE after the EFFECTIVE DATE
of this AGREEMENT whether or not the New Works of Authorship that relate to the
preparation and sale of herbal, phyto-pharmaceutical and neutrabiotic products;
(3) all New Trade Marks, Service Marks, Trade Names, and Trade Dress created
and/or used solely by LICENSEE after EFFECTIVE DATE of this AGREEMENT that
relate to the

                                       14
<PAGE>

preparation and sale of herbal, phyto-pharmaceutical and neutrabiotic products;
and (4) all discoveries, improvements and inventions, conceived during the term
of this AGREEMENT, including but not limited to improvement inventions, and any
improvements, to the TECHNICAL INFORMATION, made solely by LICENSEE's personnel
(collectively, hereinafter referred to as "LICENSEE'S INTELLECTUAL PROPERTY").

         10.09 Under the conditions enumerated in this Section 10.09 of this
AGREEMENT, LICENSEE agrees to and hereby does assign, and agrees to execute all
documents necessary to assign, right, title and interest in and to all of
LICENSEE'S INTELLECTUAL PROPERTY, together with goodwill of the business
connected with the use of and symbolized by the New Trade Marks, Service Marks,
Trade Names, and Trade Dress assigned hereunder by LICENSEE, said conditions to
be, in the event that: (1) the assets of LICENSEE are seized or attached in
conjunction with any action against it by a third party; (2) LICENSEE is
adjudged bankrupt, or becomes insolvent, or makes an assignment for the benefit
of creditors, or is placed in the hands of a receiver or a trustee in
bankruptcy; (3) normal conduct of LICENSEE's business as a private enterprise
ceases or is substantially altered as a consequence of action taken by
government or is substantially altered as a consequence of a FORCE MAJEURE.

         10.10 The provisions and obligations under Article 10 of this AGREEMENT
shall survive early and normal termination and expiration of this AGREEMENT and
shall continue in full force and effect until such time as LICENSOR elects to
abandon such terms.

11.      RECORDS

         11.00 LICENSEE agrees to keep true and accurate records, files, and
books of account containing all the data reasonably required for the full
computation and verification of the royalties to be paid and the information
affecting payments hereunder and to be given in the reports provided for
hereunder, throughout the term of this AGREEMENT and for a reasonable period of
not less than five (5) years thereafter.

         11.01 LICENSEE agrees to permit its books and records to be examined
from time to time to the extent necessary to verify such reports, such
examination to be made at the expense of LICENSOR or the FOUNDATION by an
auditor appointed by LICENSOR or the FOUNDATION who shall be acceptable to
LICENSEE, or by a certified public accountant appointed by LICENSOR or the
FOUNDATION; provided that only those royalties paid by the LICENSEE to LICENSOR
or the FOUNDATION within the five (5) year period immediately preceding the
start of the audit, and their supporting records, files, and books of account
shall be subject to audit.

12.      NONASSIGNABILITY

         12.00 This AGREEMENT imposes personal obligations on LICENSEE. LICENSEE
shall not assign any rights under this AGREEMENT not specifically transferable
by its terms without the written consent of LICENSOR.

         12.01 LICENSOR may assign its rights hereunder.

                                       15
<PAGE>

         12.02 This AGREEMENT is binding upon and shall inure to the benefit of
each of the PARTIES hereto and their respective subsidiaries, affiliates,
predecessors, successors, divisions, shareholders, directors, officers,
employees, agents, representatives, heirs and assigns.

13.      SEVERABILITY

         13.00 The PARTIES agree that if any part, term, or provision of this
AGREEMENT shall be found illegal or in conflict with any valid controlling law,
the validity of the remaining provisions shall not be affected thereby.

         13.01 In the even the legality of any provision of this AGREEMENT is
brought into question because of a decision by a court of competent jurisdiction
of any country in which this AGREEMENT applies, LICENSOR, by written notice to
LICENSEE, may revise the provision in question or may delete it entirely so as
to comply with the decision of said court.

14.      PUBLICITY

         14.00 Notwithstanding LICENSEE's right to use the TRADE MARKS subject
to the terms of this AGREEMENT, in publicizing the manufacture, use and/or sale
of LICENSED PRODUCTS, LICENSEE shall not use the name of LICENSOR or otherwise
refer to any organization related to LICENSOR, except with the written approval
of LICENSOR.

15.      WAIVER, INTEGRATION, ALTERATION

         15.00 The waiver of a breach hereunder may be effected only by a
writing signed by this waiving PARTY and shall not constitute a waiver of any
other breach.

         15.01 This AGREEMENT represents the entire understanding between the
PARTIES, and supersedes all other agreements, express or implied, between the
PARTIES concerning the INTELLECTUAL PROPERTY.

         15.02 A provision of this AGREEMENT may be altered only by a writing
signed by both PARTIES, except as provided in Section 13.01, above.

16.      COOPERATION

         16.00 Each PARTY shall execute any instruments reasonably believed by
the other PARTY to be necessary to implement the provision of this AGREEMENT.
The provisions and obligations under Section 16.00 of this AGREEMENT shall
survive early and normal termination and expiration of this AGREEMENT and shall
continue in full force and effect until such time as LICENSOR elects to abandon
such terms.

                                       16
<PAGE>

17.      CONSTRUCTION

         17.00 This AGREEMENT shall be construed in accordance with the
substantive laws of the State of Nevada of the United States of America. The
provisions and obligations under Section 17.00 of this AGREEMENT shall survive
early and normal termination and expiration of this AGREEMENT and shall continue
in full force and effect until such time as LICENSOR elects to abandon such
terms.

18.      EXPORTATION OF TECHNICAL INFORMATION; COMPLIANCE WITH LAWS

         18.00 LICENSEE agrees to comply with the laws and rules of the U.S. and
Canadian governments regarding prohibition of exportation of the TECHNICAL
INFORMATION furnished to a LICENSEE either directly or indirectly by LICENSOR.

         18.01 Each PARTY shall in its performance under the AGREEMENT conform
to all applicable state, local, and federal laws and regulations of the U.S. and
Canada.

19.      CHOICE OF LAW

         19.00 This AGREEMENT and the relationships between the PARTIES shall be
construed in accordance with the substantive laws of the State of Nevada in the
United States, without regard to its conflict of laws rules, except that
questions affecting the construction or enforcement of any INTELLECTUAL PROPERTY
rights shall be determined by the laws under which such rights are granted,
registered, or protected. The provision and obligations under Section 19.00 of
this AGREEMENT shall survive early and normal termination and expiration of this
AGREEMENT and shall continue in full force and effect until such time as
LICENSOR elects to abandon such terms.

20.      CHOICE OF LANGUAGE

         20.00 In the event of controversy between the PARTIES respecting the
interpretation or application of the terms of this AGREEMENT, the English
language version of the AGREEMENT shall be controlling. The provisions and
obligations under Section 20.00 of this AGREEMENT shall survive early and normal
termination and expiration of this AGREEMENT and shall continue in full force
and effect until such time as LICENSOR elects to abandon such terms.

21.      JURISDICTION

         21.00 Any controversy or dispute arising out of or in connection with
this AGREEMENT, its interpretation, performance, or termination shall be brought
in the courts of the Province of Alberta, Canada, and the PARTIES hereby
irrevocably and unconditionally consent to the exclusive jurisdiction of such
courts and waive any claim or inconvenient form. The prevailing PARTY in any
action or proceeding brought concerning this AGREEMENT shall be entitled to
recover its attorneys' fees and costs as an additional element of damages, or as
a cost. The provisions and obligations under

                                       17
<PAGE>

Section 21.00 of this AGREEMENT shall survive early and normal termination and
expiration of this AGREEMENT and shall continue in full force and effect until
such time as LICENSOR elects to abandon such terms.

22.      RETROACTIVITY AND CONTINUED PRACTICE

         22.00 In the even the PARTIES hereto commence actions and/or activities
permitted by this AGREEMENT prior to the formal execution of this AGREEMENT, or
continued such actions and/or activities after the formal termination or
expiration of this AGREEMENT, then the terms and conditions hereof shall be
deemed to be controlling by and between the PARTIES. Such post-expiration and/or
post-termination relationship by and between the PARTIES shall be terminable by
either PARTY on ten (10) days written notice.

23.      GENERAL PROVISIONS

         23.00 FORCE MAJEURE: If either PARTY is prevented from or delayed in
carrying out any of the provisions of this AGREEMENT by reason of any Act of
God, natural disaster, or war, or by reason of any law, order, proclamation,
regulation, ordinance, demand or requirement of any government or any
subdivision, authority or representative of any such government, the PARTY so
prevented or delayed shall be excused from performance to the extent and during
the period of such prevention or delay.

         23.01 TIME IS OF THE ESSENCE: Each PARTY acknowledges and agrees that
         time is of the essence with respect to the obligations provided by this
         AGREEMENT.

         23.02 INDEPENDENT CONTRACTORS: The PARTIES acknowledges and agree that
         they are independent contractors, and neither PARTY is, and neither
         PARTY shall represent that it is, the agent, employee, partner, or
         joint venturer of the other. Neither PARTY shall have the authority or
         power to act for, bind, or commit the other PARTY in any way.

         23.03 COUNTERPARTS: This AGREEMENT may be executed either as a single
document or in one or more counterparts, each of which shall be deemed an
original.

         23.04 NOTICES: For the purpose of all written communications and
notices between the PARTIES, their addresses shall be:

         LICENSOR:          297, rue Morin
                       ----------------------------------------
                            Ste. Adele, Quebec J8 2P8
                       ----------------------------------------
                            CANADA
                       ----------------------------------------

                       ----------------------------------------
and

                                       18
<PAGE>

         LICENSEE:          1181 Grier Drive
                       ----------------------------------------
                            Suite C
                       ----------------------------------------
                            Las Vegas, NV  89119
                       ----------------------------------------
                            U.S.A.
                       ----------------------------------------

and

         FOUNDATION:        1181 Grier Drive
                       ----------------------------------------
                            Suite C
                       ----------------------------------------
                            Las Vegas, NV  89119
                       ----------------------------------------
                            U.S.A.
                       ----------------------------------------

or any other addresses of which either PARTY shall notify the other PARTY in
writing. All notices or other official communications pertaining to this
AGREEMENT must be in writing, signed by the authorized PARTY and sent by
personal delivery, or private tracked mail delivery, or by confirmed facsimile.
Any such notice shall be deemed given upon receipt. If there is no person that
will accept such notice, then notice shall be deemed given three days after
delivery is attempted by any of these three methods of notice.

         IN WITNESS WHEREOF the PARTIES have caused this AGREEMENT to be
executed by their duly authorized officers on the respective dates and at the
respective places hereinafter set forth.

LICENSEE:
JURAK CORPORATION WORLD WIDE, INC.
ATTEST:
By:                                          By:
   ------------------------------               -------------------------------
Name:       Roger Theriault
     ----------------------------
Title:      President
      ---------------------------
Signed at:  Las Vegas                        Date:       November 29, 1998
          -----------------------                 -----------------------------

LICENSOR
LICENSEE:
JURAK HODINGS LIMITED
ATTEST:
By:                                          By:
   ------------------------------               -------------------------------
Name:       Anthony Carl Jurak
     ----------------------------
Title:      President
      ---------------------------
Signed at:  Las Vegas                        Date:       November 29, 1998
          -----------------------                 -----------------------------

                                       19Exhibit 10.1

 

INDEMNIFICATION AGREEMENT

               
This Indemnification Agreement (this "Agreement") is made as of the 28th
day of April, 2005 by and between Astronics Corporation, a New York corporation
(the "Corporation") and «Name» ("Indemnitee"), a director, officer or key
employee of the Corporation.

WITNESSETH:

               
WHEREAS, it is essential to the Corporation to retain and attract directors,
officers and key employees who are the most capable persons available; 

               
WHEREAS, the Indemnitee is serving or has agreed to serve as a director, officer
or key employee of the Corporation and in such capacity will render valuable
services to the Corporation;

               
WHEREAS, the substantial increase in corporate litigation subjects directors,
officers and key employees to expensive litigation risks at the same time that
the availability of directors' and officers' liability insurance and fiduciary
insurance has been severely limited; 

               
WHEREAS, it is now, and has always been, the express policy of the Corporation
to indemnify its directors, officers and key employees so as to provide them
with the maximum possible protection permitted by law; and

               
WHEREAS, Indemnitee may not be willing to serve or to continue to serve as a
director, officer or key employee without adequate protection, and the
Corporation desires Indemnitee to continue to serve in such capacity.

               
NOW, THEREFORE, in consideration of the Indemnitee's continued service as a
director, officer or key employee of the Corporation, the Corporation and
Indemnitee do hereby agree as follows:

        1.     
Agreement to Serve. Indemnitee agrees to continue to serve
as a director, officer or key employee of the Corporation for so long as he or
she is duly elected or appointed or until such time as he or she tenders his or
her resignation in writing. This provision is not a guarantee of employment.

        2.     
Definitions. As used in this Agreement:

               
(a)     The term "Proceeding" shall include any
threatened, pending, or completed action, suit, or proceeding, whether brought
by or in the right of the Corporation or one of its subsidiaries or otherwise,
and whether of a civil, criminal, administrative, or investigative nature, in
which Indemnitee is or was a party or is threatened to be made a party by reason
of the fact that Indemnitee is or was a director, officer or employee of the
Corporation (or any subsidiary of the Corporation), or is or was serving at the
request of the Corporation as a director, officer, employee, member, manager,
trustee, agent, or fiduciary of another corporation, limited liability company,
partnership, joint venture, trust, or other enterprise.

-2-

               
(b)     The term "Expenses" shall include, without
limitation, expenses of investigation, judicial or administrative proceedings or
appeals, amounts paid in settlement by or on behalf of Indemnitee, attorneys'
fees and disbursements, experts' fees and disbursements and any expenses of
establishing a right to indemnification under Paragraph 7 of this Agreement.

               
(c)     References to "other enterprises" shall
include employee benefit plans; references to "fines" shall include any excise
taxes assessed on Indemnitee with respect to any employee benefit plan;
references to "serving at the request of the Corporation" shall include any
service as a director, officer, employee or agent of the Corporation which
imposes duties on, or involves services by, such director, officer, employee,
agent, or fiduciary with respect to an employee benefit plan, its participants,
or beneficiaries; and a person who acted in good faith and in a manner he or she
reasonably believed to be in the interest of the participants and beneficiaries
of an employee benefit plan shall be deemed to have acted in a manner "not
opposed to the best interest of the Corporation" as referred to in this
Agreement.

        3.     
Indemnity in Third-Party Proceedings. The Corporation shall
indemnify Indemnitee in accordance with the provisions of this Paragraph 3,
against all Expenses, judgments, fines, and penalties actually and reasonably
incurred by Indemnitee in connection with the defense or settlement of any
Proceeding (other than a Proceeding by or in the right of the Corporation to
procure a judgment in its favor) if Indemnitee acted in good faith and in a
manner which he or she reasonably believed to be in or not opposed to the best
interests of the Corporation, and, in the case of a criminal proceeding, had no
reasonable cause to believe that his or her conduct was unlawful. The
termination of any such Proceeding by judgment, order, settlement, conviction,
or upon a plea of nolo contendere or its equivalent, shall not, of itself,
create a presumption that Indemnitee did not act in good faith in a manner which
he or she reasonably believed to be in or not opposed to the best interests of
the Corporation, and, with respect to any criminal proceeding, that Indemnitee
did not have reasonable cause to believe that his or her conduct was unlawful.

        4.     
Indemnity in Proceedings By or In the Right of the Corporation. 
The Corporation shall indemnify Indemnitee, in accordance with the
provisions of this Paragraph 4, against all Expenses actually and reasonably
incurred by Indemnitee in connection with the defense or settlement of any
Proceeding by or in the right of the Corporation to procure a judgment in its
favor, including the amount of the judgment or settlement, if Indemnitee acted
in good faith and in a manner which he or she reasonably believed to be in or
not opposed to the best interests of the Corporation; provided, however, that no
indemnification for Expenses shall be made under this Paragraph 4 in respect of
any claim, issue, or matter as to which Indemnitee shall have been adjudged to
be liable to the Corporation unless and only to the extent that the court in
which such Proceeding was brought, or, if no action was brought, any court of
competent jurisdiction, determines upon application that, despite the
adjudication of liability but in view of all the circumstances of the case,
Indemnitee is fairly and reasonably entitled to indemnity for the Expenses and
the amount of the judgment or settlement which the court shall deem proper.

-3-

        5.     
Indemnification of Expenses of Successful Party. 
Notwithstanding any other provision of this Agreement, to the extent that
Indemnitee has been successful on the merits or otherwise, in defense of any
Proceeding, or in defense of any claim, issue, or matter therein, Indemnitee
shall be indemnified against all Expenses actually and reasonably incurred by
Indemnitee in connection therewith to the fullest extent permitted by New York
Law.

        6.     
Advances of Expenses. At the written request of Indemnitee,
the Expenses actually and reasonably incurred by Indemnitee in any Proceeding
shall be paid by the Corporation in advance of the final disposition of such
Proceeding and within 30 days after request therefor. Indemnitee will repay any
such Expenses that are advanced under this Paragraph 6 if it is ultimately
determined, in a final, non-appealable judgment rendered by the court of last
resort (or by a lower court if not timely appealed), that Indemnitee is not
entitled to be indemnified against such Expenses. This undertaking by Indemnitee
is an unlimited general undertaking but no security for such undertaking will be
required. If the Corporation makes an advance of expenses pursuant to this
Paragraph 6, the Corporation shall be subrogated to every right of recovery
Indemnitee may have against any insurance carrier from whom the Corporation has
purchased insurance for such purpose.

        7.     
Right of Indemnitee to Indemnification Upon Application; Procedure Upon
Application.

               
(a)     Subject to Paragraph 8 of this Agreement,
Indemnitee will be presumed to be entitled to indemnification under this
Agreement. The burden of proving that indemnification or advances of Expenses
are not appropriate shall be on the Corporation.

               
(b)     Any indemnification under Paragraphs 3 and 4
(other than the advancement of Expenses) shall be paid by the Corporation no
later than 30 days after receipt of the written request of Indemnitee, unless a
determination is made within the 30-day period by (i) the Board of Directors by
a majority vote of directors who are not and were not parties to the Proceeding
in respect of which indemnification is being sought ("Disinterested Directors"),
(ii) a committee of the Board of Directors comprised of Disinterested Directors
or (iii) independent legal counsel in a written opinion (which counsel shall be
appointed by a vote of the Disinterested Directors), that Indemnitee has not met
the relevant standards for indemnification set forth in Paragraphs 3 and 4. If
requested by the Indemnitee in writing, any such determination shall be made by
independent legal counsel not previously employed by the Corporation or any
Affiliate thereof ("Affiliate" having the meaning defined in Rule 144
promulgated by the Securities and Exchange Commission under the Securities Act
of 1933, as amended).

               
(c)     Indemnitee will be entitled to a hearing
before the Board of Directors of Corporation or the Disinterested Directors
and/or any other person or persons making a determination and evaluation under
Paragraph 7(b). Indemnitee will be entitled to be represented by counsel at
such hearing. The cost of any determination and evaluation under Paragraph
7(b) (including attorneys' fees and other expenses incurred by Indemnitee in
preparing for and attending the hearing contemplated by Paragraph 7 and
otherwise in connection with the determination and evaluation under Paragraph 7)
will be borne by the Corporation.

-4-

               
(d)     The right to indemnification or advancement
of Expenses as provided by this Agreement shall be enforceable by Indemnitee in
any court of competent jurisdiction. Neither the failure of the Corporation
(including its Board of Directors or independent legal counsel) to have made a
determination prior to the commencement of such action that Indemnitee has met
the applicable standard of conduct nor an actual determination by the
Corporation (including its Board of Directors or independent legal counsel) that
Indemnitee has not met such standard shall be a defense to the action or create
a presumption that Indemnitee has not met the applicable standard of conduct.
Indemnitee's Expenses actually and reasonably incurred in connection with
successfully establishing his or her right to indemnification or advances, in
whole or in part, shall also be indemnified by the Corporation.

               
(e)     With respect to any Proceeding for which
indemnification is requested, the Corporation will be entitled to participate
therein at its own expense and, except as otherwise provided below, the
Corporation may assume the defense thereof, with counsel satisfactory to
Indemnitee. After notice from the Corporation to Indemnitee of its election to
assume the defense of a Proceeding, the Corporation will not be liable to
Indemnitee under this Agreement for any Expenses subsequently incurred by
Indemnitee in connection with the defense thereof, other than as provided below.
The Corporation shall not settle any Proceeding in any manner which would impose
any penalty or limitation on Indemnitee without Indemnitee's written consent.
Indemnitee shall have the right to employ counsel in any Proceeding but the fees
and expenses of such counsel incurred after notice from the Corporation of its
assumption of the defense of the Proceeding shall be at the expense of
Indemnitee, unless (i) the employment of counsel by Indemnitee has been
authorized by the Corporation, (ii) Indemnitee shall have reasonably concluded
that there may be a conflict of interest between the Corporation and Indemnitee
in the conduct of the defense of a Proceeding, or (iii) the Corporation shall
not in fact have employed counsel to assume the defense of a Proceeding, in each
of which cases the fees and expenses of Indemnitee 's counsel shall be advanced
by the Corporation. Notwithstanding the foregoing, the Corporation shall not be
entitled to assume the defense of any Proceeding brought by or in the right of
the Corporation.

               
(f)     The Corporation shall pay to Indemnitee, at
the time payments are made to Indemnitee for Expenses, judgments, fines or
penalties pursuant to this Agreement, an additional payment (the "Gross Up
Amount") such that after payment of all taxes, if any, on payments so made,
including the amount of the Gross Up Amount, Indemnitee retains an amount equal
to the amount to be received.

        8.     
Limitation on Indemnification. No payment pursuant to this
Agreement shall be made by the Corporation:

               
(a)     to indemnify or advance funds to Indemnitee
for Expenses with respect to Proceedings initiated or brought or joined in
voluntarily by Indemnitee and not by way of defense, except with respect to
Proceedings brought to establish or enforce a right to indemnification or
advancement of Expenses under this Agreement or as otherwise required by New
York law, but such indemnification or advancement of Expenses may be provided by
the Corporation in specific cases if the Board of Directors finds it to be
appropriate;

-5-

               
(b)     to indemnify Indemnitee for any Expenses,
judgments, fines or penalties sustained in any Proceeding for which payment is
actually made to Indemnitee under a valid and collectible insurance policy,
except in respect of any excess beyond the amount of payment under such
insurance;

               
(c)     to indemnify Indemnitee for any Expenses,
judgments, fines or penalties sustained in any Proceeding for an accounting of
profits made from the purchase or sale by Indemnitee of securities of the
Corporation pursuant to the provisions of § 16(b) of the Securities Exchange Act
of 1934, the rules and regulations promulgated thereunder and amendments thereto
or similar provisions of any federal, state, or local statutory law; or

               
(d)     if a court of competent jurisdiction finally
determines that such payment hereunder is unlawful.

        9.     
Indemnification Hereunder Not Exclusive. The
indemnification and advancement of Expenses provided by this Agreement shall not
be deemed exclusive of any other rights to which indemnitee may be entitled
under the Certificate of Incorporation or the By-Laws of the Corporation, any
agreement, any vote of stockholders or disinterested Directors, the Business
Corporation Law of the State of New York, or otherwise, both as to action in his
official capacity and as to action in another capacity while holding such
office. To the extent the provisions of this Agreement conflict with the
provisions regarding indemnification and advancement of Expenses in the By-Laws
of the Corporation, this Agreement will control. The indemnification
provided by this Agreement shall continue as to Indemnitee even though he or she
may have ceased to be a director, officer or key employee and shall inure to the
benefit of the heirs and personal representatives of Indemnitee.

        10.     
Partial Indemnification. If Indemnitee is entitled under
any provision of this Agreement to indemnification by the Corporation for a
portion of the Expenses, judgments, fines or penalties actually and reasonably
incurred by him or her in any Proceeding but not, however, for the total amount
thereof, the Corporation shall nevertheless indemnify Indemnitee for the portion
of such Expenses, judgments, fines or penalties to which Indemnitee is entitled.

        11.     
Indemnification of Indemnitee's Estate. Notwithstanding any other
provision of this Agreement, and regardless whether indemnification of the
Indemnitee would be permitted and/or required under this Agreement, if the
Indemnitee is deceased, the Corporation shall indemnify and hold harmless the
Indemnitee's estate, spouse, heirs, administrators, personal representatives and
executors (collectively the "Indemnitee's Estate") against, and the Corporation
shall assume, any and all claims, damages, Expenses, penalties, judgments and
fines actually incurred by the Indemnitee or the Indemnitee's Estate in
connection with the investigation, defense, settlement or appeal of any
Proceeding. Indemnification of the Indemnitee's Estate pursuant to this Section
11 shall be mandatory and not require any determination or finding that the
Indemnitee's conduct satisfied a particular standard of conduct.

-6-

        12.     
Spousal Indemnification. The indemnifications, benefits and
obligations of this Agreement shall extend to the spouse of an Indemnitee in the
event that the spouse is made a party to a Proceeding or collection, execution
or enforcement efforts arising from a Proceeding. 

        13.     
Limitation of Actions and Release of Claims. No proceeding shall
be brought and no cause of action shall be asserted by or on behalf of the
Corporation or any subsidiary against the Indemnitee, his or her spouse, heirs,
estate, executors or administrators after the expiration of one year from the
act or omission of the Indemnitee upon which such proceeding is based; however,
in a case where the Indemnitee fraudulently conceals the facts underlying such
cause of action, no proceeding shall be brought and no cause of action shall be
asserted after the expiration of one year from the earlier of (i) the date the
Corporation or any subsidiary of the Corporation discovers such facts, or (ii)
the date the Corporation or any subsidiary of the Corporation could have
discovered such facts by the exercise of reasonable diligence. Any claim or
cause of action of the Corporation or any subsidiary of the Corporation,
including claims predicated upon the act or omission of the Indemnitee, shall be
extinguished and deemed released unless asserted by filing of a legal action
within such period. This section shall not apply to any cause of action which
has accrued on the date hereof and of which the indemnitee is aware on the date
hereof, but as to which the Corporation has no actual knowledge apart from the
Indemnitee's knowledge.

        14.     
Maintenance of Liability Insurance.

               
(a)     The Corporation hereby covenants and agrees
that, as long as Indemnitee continues to serve as a director, officer or key
employee of the Corporation and thereafter as long as Indemnitee may be subject
to any Proceeding, the Corporation, subject to subsection (c) below, shall
maintain in full force and effect directors' and officers' liability insurance
("D&O Insurance") in reasonable amounts from established and reputable insurers.

               
(b)     In all D&O Insurance policies, Indemnitee
shall be named as an insured in such a manner as to provide the Indemnitee the
same rights and benefits as are accorded to the most favorably insured of the
Corporation's directors and officers.

               
(c)     Notwithstanding the foregoing, the
Corporation shall have no obligation to obtain or maintain D&O Insurance if the
Corporation determines in good faith that such insurance is not reasonably
available, the premium costs for such insurance are disproportionate to the
amount of coverage provided, the coverage provided by such insurance is so
limited by exclusions that it provides an insufficient benefit, or Indemnitee is
covered by similar insurance maintained by a subsidiary of the Corporation.

        15.     
Savings Clause. If this Agreement or any portion hereof is
invalidated on any ground by any court of competent jurisdiction, the
Corporation shall nevertheless indemnify Indemnitee to the extent permitted by
any applicable portion of this Agreement that has not been invalidated or by any
other applicable law.

        16.     
Notice. Indemnitee shall, as a condition precedent to his
or her right to be indemnified under this Agreement, give to the Corporation
notice in writing as soon as practicable of any Proceeding for which indemnity
will or could be sought under this Agreement. Notice to the Corporation shall be
directed to Astronics Corporation, 130 Commerce Way, East Aurora, New York
14052, Attention: Corporate Secretary (or such other address as the Corporation
shall designate in writing to Indemnitee). Notice shall be deemed received three
days after the date postmarked if sent by prepaid mail, properly addressed. In
addition, Indemnitee shall give the Corporation such information and cooperation
as it may reasonably require and as shall be within Indemnitee's power.

-7-

        17.     
Counterparts. This Agreement may be executed in any number
of counterparts, all of which shall be deemed to constitute one and the same
instrument.

        18.     
Applicable Law. This Agreement shall be governed by, and
construed and interpreted in accordance with, the law of the State of New York

        19.     
Successors and Assigns. This Agreement shall be binding
upon the Corporation and its successors and assigns.

        20.     
Amendments. No amendment, waiver, modification,
termination, or cancellation of this Agreement shall be effective unless in
writing signed by both parties hereto. The indemnification rights afforded to
Indemnitee hereby are contract rights and may not be diminished, eliminated, or
otherwise affected by amendments to the Certificate of Incorporation or Bylaws
of the Corporation or by other agreements.

        21.     
Cessation of Employment. The benefits of this Agreement shall
extend to and include officers, directors and key employees of the Corporation
who retire or cease their employment with the Corporation.

        22.     
Prior Agreements. This Agreement replaces and supersedes all prior
agreements dealing with the same subject matter as this Agreement.

        23.     
Cooperation and Interest. The Corporation shall cooperate in good
faith with the Indemnitee and use its best efforts to ensure that the Indemnitee
is indemnified and/or reimbursed for liabilities described in this Agreement to
the fullest extent permitted by law.

        24.     
Effective Date. The provisions of this Agreement shall cover
claims, actions, suits and proceedings, whether now pending or hereafter
commenced, and shall be retroactive to cover acts or omissions or alleged acts
or omissions which heretofore have taken place.

 

-8-

               
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly
executed and signed as of the day and year first above written.

	Attest: 	ASTRONICS CORPORATION
	 	 
	 	 
	___________________________	By:______________________________ 
	Secretary	         Name
		         Title
	 	 
	 	 
	 	_____________________________
	 	        
    Indemnitee

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}]]